Santen Pharmaceutical Co., Ltd. (TYO:4536)
1,867.00
-21.50 (-1.14%)
Jun 19, 2026, 3:15 PM JST
Santen Pharmaceutical Market Cap
Santen Pharmaceutical has a market cap or net worth of 607.49 billion as of June 18, 2026. Its market cap has increased by 11.89% in one year.
Market Cap
607.49B
Enterprise Value
525.64B
Revenue
291.62B
Ranking
n/a
PE Ratio
16.59
Stock Price
1,867.00
Market Cap Chart
Since January 14, 1992, Santen Pharmaceutical's market cap has increased from 150.82B to 607.49B, an increase of 302.80%. That is a compound annual growth rate of 4.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 607.49B | 16.17% |
| Dec 30, 2025 | 522.95B | -5.35% |
| Dec 30, 2024 | 552.48B | 8.00% |
| Dec 29, 2023 | 511.57B | 23.49% |
| Dec 30, 2022 | 414.25B | -26.39% |
| Dec 30, 2021 | 562.77B | -15.93% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 12.38T |
| Otsuka Holdings | 5.45T |
| Daiichi Sankyo Company | 4.58T |
| Astellas Pharma | 3.84T |
| Kyowa Kirin | 1.25T |
| Ono Pharmaceutical | 1.06T |
| JCR Pharmaceuticals | 54.65B |
| Perseus Proteomics | 2.46B |